Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project-Reference-Cited by-同舟云学术

Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project

Published:2016-11-28 Issue:4 Volume:40 Page:222-229
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Li Wen‐Hua¹²,Huang Duo¹,Chiang Chern‐En³,Lau Chu‐Pak¹,Tse Hung‐Fat¹,Chan Esther W.⁴,Wong Ian C.K.⁴,Lip Gregory Y. H.⁵,Chan Pak‐Hei¹,Siu Chung‐Wah¹

Affiliation:

1. Cardiology Division, Department of Medicine, Li Ka Shing Faculty of MedicineThe University of Hong Kong Hong Kong China

2. Department of Echocardiography and Noninvasive Cardiology LaboratorySichuan Academy of Medial Science and Sichuan Provincial People's Hospital Chengdu Sichuan China

3. Division of Cardiology, Taipei Veterans General HospitalNational Yang‐Ming University Taipei Taiwan

4. Department of Pharmacology and PharmacyThe University of Hong Kong Hong Kong, China

5. University of Birmingham Centre for Cardiovascular SciencesCity Hospital Birmingham United Kingdom

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.22649

Reference18 articles.

1. An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland China

2. Ethnic Differences in Atrial Fibrillation Identified Using Implanted Cardiac Devices